Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$453.82M-113%-$364.89M-87.5%-$305.21M-95.3%-$247.79M-86.0%-$213.42M-84.0%
$2.35M+38.7%$2.27M+30.7%$2.06M+28.9%$1.76M+9.9%$1.69M+9.9%
$87.3M+248%$33.7M+50.2%$30.78M+48.2%$28.83M+45.8%$25.08M+54.8%
-$354.17M-82.2%-$274.24M-98.3%-$207.31M-59.0%-$221.76M-73.0%-$194.44M-21.1%
$1.54M-52.9%$1.93M+57.5%$3.35M-4.9%$7.45M+211%$3.27M+3.1%
$172.62M+1,182%$74.88M+119%$24.85M+216%$34.28M-$15.95M+93.6%
$238.74M+27,216%$365.66M-58.2%$0-100%$256.58M+3,319%$874K+7.9%
$57.19M+127%-$184.05M-147%-$209.51M+48.6%
-$355.7M-79.9%-$276.16M-97.9%-$210.66M-57.3%-$229.21M-75.5%-$197.7M-20.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Revolution Medicines, Inc. generate?
Revolution Medicines, Inc. (RVMD) generated -$1.1B in operating cash flow over the trailing twelve months.
What is Revolution Medicines, Inc.'s free cash flow?
After $14.3M of capital expenditures, Revolution Medicines, Inc.'s free cash flow was -$1.1B over the trailing twelve months, down 78.1% year over year.
Where does Revolution Medicines, Inc.'s cash flow data come from?
Every line is extracted from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.